Just like people, no two lung cancer tumors are identical. In recent years, the most effective lung cancer research involves a technique known as precision medicine. Also referred to as personalized medicine, precision medicine tailors treatment to each patient
...
For many doctors, their dream to be scientists begins when they are children. It is often the very fabric of their being that, when they grow up, they want to be in the business of healing, making discoveries, and
...
Small cell lung cancer life expectancy and the need for more research Lung cancer research has made many wonderful advances in just the past few years. However, small cell lung cancer life expectancy has not increased as quickly as
...
Meet Our Young Investigators Since its establishment in 2007, LCFA has funded over $4 million dollars in lung cancer research grants in partnership with organizations such as the largest international clinical society focusing on lung cancer, the IASLC (International
...
Clinical trials are just that: research programs conducted with patients to determine if an investigational treatment, drug, or device is a better line of defense than the current “best standard of care.” Clinical trials are taking place all over
...
LCFA presents lung cancer research grant opportunities to researchers worldwide who present the “best in science” projects in the field. These annual lung cancer research grant awards are 6-figure grants, allowing the researcher to set up a lab, hire
...
From Antidote.me A lot has changed since the Lung Cancer Foundation of America was founded around 10 years ago by two lung cancer survivors and a lung cancer widow. Today, the LCFA funds some of the most innovative research…
From Science and Technology Research News A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was…
From ePRNews LOS ANGELES – May 11, 2018 – Lung Cancer Foundation of America (LCFA)and the International Association for the Study of Lung Cancer (IASLC) have awarded a pair of two-year grants, generously funded in part by Bristol-Myers Squibb, to…
Vanderbilt University Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer. The Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung…